Matches in Nanopublications for { ?s ?p "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP605010.RA8IJr1WHKYUchb3xl2JTKdhh86dAx-s20z5jLFlYstes130_assertion description "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605010.RA8IJr1WHKYUchb3xl2JTKdhh86dAx-s20z5jLFlYstes130_provenance.
- NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_assertion description "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_provenance.
- assertion description "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_assertion description "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_provenance.
- NP869776.RAAgWY6kl2hxqrrqxg5SBbi0A6fewq7Q3jJGrq5QZD2CM130_assertion description "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869776.RAAgWY6kl2hxqrrqxg5SBbi0A6fewq7Q3jJGrq5QZD2CM130_provenance.
- NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_assertion description "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_provenance.
- NP869778.RAztkiIqtWXPGlneQppJCbjllNYw_IWPY4NxlL2eiRqnY130_assertion description "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869778.RAztkiIqtWXPGlneQppJCbjllNYw_IWPY4NxlL2eiRqnY130_provenance.